Written by the Nuvirox Research Team
Key points
- A small 2020 pilot trial (60 patients, 56 days) found oral sodium hyaluronate improved pain and function versus placebo and reduced NSAID use.
- This is a much smaller and shorter evidence base than injected hyaluronic acid, which has decades of research behind it.
- Oral hyaluronic acid is not the same intervention as a hyaluronic acid injection into the joint — the two shouldn't be assumed to work the same way.
Short answer: early and modest, not established. Oral hyaluronic acid has a small amount of placebo-controlled human trial support for short-term knee osteoarthritis symptoms, but the evidence base is thin compared to injected hyaluronic acid, which is a genuinely different intervention with its own separate track record.
What hyaluronic acid actually does in a joint
Hyaluronic acid (HA) is a naturally occurring component of synovial fluid, the lubricating fluid inside your joints. It gives synovial fluid its viscosity and shock-absorbing properties. In osteoarthritis, the concentration and molecular weight of hyaluronic acid in joint fluid tends to decrease, which is part of why doctors have injected HA directly into arthritic joints (viscosupplementation) for decades as a treatment option.
Oral hyaluronic acid supplements are a newer, different idea: swallowing HA and hoping enough of it (or its breakdown products) reaches joint tissue to matter. This is mechanistically less direct than an injection placed straight into the joint capsule.
What does the oral evidence actually show?
The clearest placebo-controlled data point is a 2020 pilot study: 60 adults with knee osteoarthritis randomized to a sodium hyaluronate formulation (FS-HA) with a broad range of molecular weights, or placebo, for 56 days. The treatment group showed significant improvement in pain (VAS), WOMAC pain and total scores, and the Lequesne Functional Index compared to baseline, and outperformed placebo at day 60 on pain scores. The treatment group also used fewer NSAIDs or pain medications during the trial Cicero AFG, Girolimetto N, Bentivenga C, et al. Short-Term Effect of a New Oral Sodium Hyaluronate Formulation on Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Diseases. 2020;8(3):26. doi:10.3390/diseases8030026.
A separate 8-week randomized, double-blind trial tested low molecular weight liquid hyaluronic acid combined with glucosamine and chondroitin against placebo in patients with mild knee osteoarthritis pain, reporting benefit for the combination Wang SJ, Wang YH, Huang LC. The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: an 8-week randomized double-blind placebo-controlled trial. Medicine (Baltimore). 2021;100(6):e24252. doi:10.1097/MD.0000000000024252.
Honest counterweight: both of these are small (60 and under 100 patients respectively), short (8 weeks and 56 days), and in the case of the combination trial, don't isolate hyaluronic acid's individual contribution from glucosamine and chondroitin. This is a much thinner, shorter evidence base than injected HA, which has been studied in far larger, longer trials (with its own separate mixed track record, including questions raised by systematic reviews about the size of its benefit).
Oral HA vs. injected HA: not the same thing
It's worth being direct about this distinction because marketing sometimes blurs it: an intra-articular hyaluronic acid injection places the substance directly into the joint space, bypassing digestion entirely. Oral HA has to survive digestion, get absorbed, and somehow influence joint tissue from the bloodstream — a mechanistically longer and less certain path. Don't assume that because injected HA has decades of use, oral HA inherits that same track record; it doesn't. If you're specifically weighing an injection against a supplement, that's a conversation for your doctor, since injections are a medical procedure with their own separate cost, frequency, and risk considerations that this article doesn't cover.
What oral HA won't do
The available trials measured pain, stiffness, and function scores over weeks — not cartilage regeneration or long-term structural change. There's no human trial evidence that oral hyaluronic acid rebuilds the cartilage that's already been lost. If your knee is locking, giving way, or swelling significantly, that calls for a clinical evaluation rather than a supplement trial.
How it fits with other joint-support options
Because synovial fluid and cartilage are related but distinct structures, hyaluronic acid's proposed mechanism (lubrication) is different from ingredients that target cartilage matrix directly, like collagen peptides or glucosamine and chondroitin. That mechanistic difference is part of why the combination trial discussed above paired hyaluronic acid with glucosamine and chondroitin rather than testing it in isolation — researchers may see these as complementary rather than redundant approaches, though again, the isolated contribution of hyaluronic acid within that combination hasn't been separately confirmed. If you're already taking one of these other ingredients and considering adding oral HA, there's no specific safety conflict reported, though as with most supplement stacking, the added benefit beyond either ingredient alone remains unconfirmed by dedicated trials.
Why oral HA trials are smaller and newer than you might expect
Injectable hyaluronic acid has been an FDA-cleared treatment option in the United States since the 1990s, which gave it decades of head start in trial funding and research attention compared with oral formulations, which are a comparatively recent commercial development. That timeline gap is a big part of why the oral evidence base looks thinner — it isn't necessarily that oral HA has been tested and found weaker, more that it simply hasn't accumulated the same volume of research yet. Expect this evidence base to keep developing, and treat today's pilot-trial-level evidence as an early read rather than a final verdict.
Frequently asked questions
How long before oral hyaluronic acid might work, if it does?
The positive pilot trial showed a difference emerging by around 56–60 days, so a two-month trial period is a reasonable minimum before judging whether it's doing anything for you.
Is oral hyaluronic acid safe to combine with an HA injection?
There's no specific safety conflict reported in the literature, but that combination hasn't been formally studied together, so any added benefit from combining them is unproven.
What molecular weight of hyaluronic acid works best orally?
The positive pilot trial used a formulation with a deliberately broad spectrum of molecular weights rather than a single one; there isn't yet a clear human trial answer on which specific molecular weight range performs best taken by mouth.
From Nuvirox
Why we formulated Joint+ Restore
We built Joint+ Restore around the same category of joint-support ingredients researchers have studied for cartilage comfort and mobility — without pretending a capsule replaces the fundamentals of movement, weight management, and load management covered above. Our formulation approach is reviewed as the underlying science evolves, so we intentionally keep this section at the philosophy level rather than listing specific actives here.
Every order is backed by our 60-day money-back guarantee — long enough to actually decide whether it belongs in your routine.
Learn more about Joint+ Restore →The bottom line
Oral hyaluronic acid has a small, genuinely positive pilot trial behind it for short-term knee osteoarthritis symptoms, plus a low-risk safety profile — but "small pilot trial" is the honest description, not "well established." It's a reasonable ingredient to try for a couple of months, with realistic expectations about how thin the evidence still is.
References
- Cicero AFG, Girolimetto N, Bentivenga C, et al. Short-Term Effect of a New Oral Sodium Hyaluronate Formulation on Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Diseases. 2020;8(3):26. doi:10.3390/diseases8030026.
- Wang SJ, Wang YH, Huang LC. The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: an 8-week randomized double-blind placebo-controlled trial. Medicine (Baltimore). 2021;100(6):e24252. doi:10.1097/MD.0000000000024252.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.